Table 1.
No Stretch | Stretch | |
---|---|---|
DHA bioactive metabolome | ||
Rv D1 | 0.04±0.007 | 0.06±0.01 |
RvD2 | 0.04±0.01 | 0.06±0.02 |
RvD3 | 0.01±0.0005 | 0.02±0.004 |
RvD5 | * | * |
RvD6 | * | * |
AT-RvD1 | 0.01±0.004 | 0.01±0.009 |
AT-RvD3 | 0.004±0.0007 | 0.006±0.001 |
PD1 | * | * |
10S, 17S-diHDHA | 0.02±0.01 | 0.03±0.005 |
MaRr1 | 0.04±0.009 | 0.04±0.005 |
7S,14S-diHDHA | * | * |
EPA bioactive metabolome | ||
RvE1 | * | * |
RvE2 | * | * |
RvE3 | 0.01±0.002 | 0.02±0.01 |
AA bioactive metabolome | ||
LXA4 | * | * |
LXB4 | 0.2±0.04 | 0.2±0.1 |
5S, 15S-diHETE | 0.5±0.1 | 0.4±0.1 |
AT-LXA4 | 0.9±0.02 | 0.1±0.06 |
AT-LXB4 | * | * |
LTB4 | 0.5±0.2 | 0.2±0.09 |
5S,12S-diHETE | * | * |
20-OH-LTB4 | * | * |
20-COOH-LTB4 | * | * |
PGD2 | 7.7±2.5 | 7.7±5.3 |
PGE2 | 17.2±2.6 | 14.8±5.9 |
PGF2a | 1.5±0.5 | 1.3±0.9 |
TXB2 | 8.6±3.1 | 11.7±8.2 |
Results are expressed as mean ± SE, normalized to the inflammatory lesion cross sectional area (n=4/group).
, Below Limit, limit ~0.1pg.